These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17053834)

  • 1. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
    Zhang J; Stirling B; Temmerman ST; Ma CA; Fuss IJ; Derry JM; Jain A
    J Clin Invest; 2006 Nov; 116(11):3042-9. PubMed ID: 17053834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
    Tsagaratou A; Grammenoudi S; Mosialos G
    Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor CYLD controls the function of murine regulatory T cells.
    Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
    J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1.
    Gommeaux J; Cano C; Garcia S; Gironella M; Pietri S; Culcasi M; Pébusque MJ; Malissen B; Dusetti N; Iovanna J; Carrier A
    Mol Cell Biol; 2007 Mar; 27(6):2215-28. PubMed ID: 17242209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
    Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
    Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.
    Allen IC; Wilson JE; Schneider M; Lich JD; Roberts RA; Arthur JC; Woodford RM; Davis BK; Uronis JM; Herfarth HH; Jobin C; Rogers AB; Ting JP
    Immunity; 2012 May; 36(5):742-54. PubMed ID: 22503542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.
    Shembade N; Harhaj NS; Liebl DJ; Harhaj EW
    EMBO J; 2007 Sep; 26(17):3910-22. PubMed ID: 17703191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.
    Zhao Y; Ma CA; Wu L; Iwai K; Ashwell JD; Oltz EM; Ballard DW; Jain A
    J Biol Chem; 2015 Sep; 290(36):22076-84. PubMed ID: 26224629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-specific disruption of recombination signal binding protein Jκ ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice.
    He F; Guo FC; Li Z; Yu HC; Ma PF; Zhao JL; Feng L; Li WN; Liu XW; Qin HY; Dou KF; Han H
    Hepatology; 2015 Jan; 61(1):303-14. PubMed ID: 25145286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.
    Urbanik T; Boger RJ; Longerich T; Becker K; Ehrenberg KR; Hövelmeyer N; Hahn M; Schuchmann M; Jäger D; Waisman A; Wörns MA; Schulze-Bergkamen H
    J Hepatol; 2012 Nov; 57(5):995-1003. PubMed ID: 22728872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
    Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
    In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutated cylindromatosis gene affects the functional state of dendritic cells.
    Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
    Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling.
    Wei J; Wei C; Wang M; Qiu X; Li Y; Yuan Y; Jin C; Leng L; Wang J; Yang X; He F
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8883-8. PubMed ID: 24879442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
    Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
    J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYLD: a multifunctional deubiquitinase.
    Glittenberg M; Ligoxygakis P
    Fly (Austin); 2007; 1(6):330-2. PubMed ID: 18820455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.